25 LLC’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

25 LLC’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2	Closed	-$568	–	603
2023 Q2	$568	Buy	+2	New	+$555	﹤0.01%	429

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

25 LLC's SWAV Position: Q3 2023 in Review

25 LLC sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2023, closing a stake of 2 shares — an estimated $568 sold.

25 LLC first reported a position in SWAV in Q2 2023 and held it in 1 quarter. The position peaked at $568 in Q2 2023. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

25 LLC reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
25 LLC sold 2 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $568.
25 LLC first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
25 LLC's Shockwave Medical, Inc. Common Stock position peaked at $568 in Q2 2023.
412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.